Hemarina
Project Morlaix, France
Breton biopharmaceutical company using the extracellular haemoglobin of the marine lugworm Arenicola marina, which carries oxygen without blood-type constraints. Its programmes cover organ graft preservation, wound treatment and blood substitutes. Founder Franck Zal received the 2026 European Inventor Award from the European Patent Office.
Gallery
Contact
Is this your project?
Claim this listing to update it yourself.
Something wrong on this page? Request a correction or a removal